Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics. [electronic resource]
Producer: 20150217Description: 145-52 p. digitalISSN:- 1872-8421
- Cytokines -- blood
- Disability Evaluation
- Female
- Flow Cytometry
- Genotype
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunologic Factors -- therapeutic use
- Male
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Pharmacogenetics
- Polymorphism, Single Nucleotide
- Prospective Studies
- RNA, Messenger -- metabolism
- Reproducibility of Results
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.